Vertex Pharmaceuticals is buying Crinetics to expand into rare hormonal diseases Jul 07, 2026 · Cris Tolomia The deal gives Vertex access to Palsonify, an oral acromegaly treatment, and atumelnant, a late-stage drug for congenital adrenal hyperplasia Read more »
